Pope R et al. Sexual function through menopause: a review of basic evaluation and treatment. BJOG, 2025. https://doi.org/10.1111/1471-0528.70041
Key takeaways
- Difficulty reaching orgasm, or orgasms feeling less intense, is a recognised and common consequence of the hormonal changes that happen during perimenopause and menopause.
- The causes are physical, not personal: falling oestrogen and testosterone affect blood flow, tissue sensitivity, and sexual response in ways that are measurable and treatable.
- Effective options exist, from vaginal oestrogen and HRT to testosterone, pelvic floor physiotherapy, and CBT, and the right combination depends on your individual picture.
Introduction
Changes to orgasm during menopause are one of the most common sexual health experiences women describe, and one of the least likely to come up in a ten-minute GP appointment. If orgasms have become harder to reach, less intense, or feel different from how they used to, you are not alone, and you are not imagining it.
Research published in the European Journal of Midwifery (2024) found that more than 1 in 5 menopausal women reported moderate to severe difficulty achieving orgasm. Many more experience subtler changes that they attribute to stress, ageing, or their relationship, rather than recognising them as a physiological response to hormonal change.
This article explains what is actually happening in your body, covers the factors that compound the problem (including some that are rarely discussed, such as the effect of antidepressants), and sets out the treatment options that have clinical evidence behind them. Because difficulty with orgasm during menopause is not something you have to accept as permanent.
If orgasms feel harder to reach, or less intense, you are not imagining it
The experience of orgasm difficulty during menopause is common enough to have its own clinical classification. Sexual dysfunction at menopause is recognised across five distinct domains: desire, arousal and lubrication, orgasm, satisfaction, and pain. A 2025 review published in BJOG confirms that decline across all five domains is a well-established feature of menopause, with orgasmic function affected by a combination of hormonal, biological, and psychosocial factors.
Research in the journal Menopause notes that prevalence data likely underestimates the true scale of the problem, because many women reduce or stop sexual activity as symptoms worsen and are then excluded from studies. If it feels like this is not talked about enough, that is because it is not talked about enough, and that absence of conversation makes women feel more isolated than the numbers justify.
You are not unusual. You are not "too old" for this to matter. And the fact that it is common does not mean it cannot be addressed.
What is happening to your body
Orgasm is not a single event. It is the result of a cascade of physiological processes: blood flow to the genitals, nerve sensitivity, muscle tension and release, hormonal signalling, and psychological engagement. Menopause affects several of these simultaneously.
A 2025 review in BJOG sets out the key pathways. Falling oestrogen reduces blood flow to genital tissue, decreases natural lubrication, and causes thinning and structural changes to the vaginal walls and vulva. This constellation of changes is now classified as genitourinary syndrome of menopause (GSM): the clinical term for the chronic, progressive condition affecting the vulva, vagina, bladder, and urethra driven by oestrogen deficiency, confirmed in the BMS Consensus Statement on GSM (2025).
“Falling testosterone adds a separate but related layer. Testosterone (often associated with men, but equally important for women's energy, mood, and libido) plays a direct role in sexual desire and the capacity for arousal. When levels decline during menopause, the drive toward sexual activity can diminish, and with it the neurological priming that makes orgasm easier to reach.”
The two processes compound each other. Reduced desire means less arousal. Less arousal means less blood flow to genital tissue. Less blood flow means reduced sensitivity and more difficulty reaching orgasm.
The clitoris: what changes and why it matters
Most conversations about menopause and sexual function focus on vaginal dryness and painful sex. The clitoris receives considerably less attention, which means many women are left without an explanation for one of the most significant physical changes affecting their experience of orgasm.
The clitoris is highly responsive to oestrogen. Reduced oestrogen during menopause affects blood flow to clitoral tissue, altering nerve sensitivity and the speed and intensity of physical response. The international consensus review published in Sexual Medicine Reviews (2025) confirms that reduced genital blood flow is a recognised contributor to orgasmic dysfunction in menopause, and that this is a direct physiological consequence of GSM, not a separate or unrelated phenomenon.
In practical terms, this can mean that stimulation that previously produced a quick or reliable response now requires more time, more direct contact, or a different kind of engagement. This is not a sign that something is permanently broken. It is a sign that the tissue has changed, and that what you do in response may need to change with it.
Understanding this mechanism is useful because it shifts the frame. Difficulty orgasming during menopause is not about effort or mindset or being "in your head." It is about a measurable reduction in blood flow and nerve sensitivity in specific tissue. And that responds to treatment.
The role of the pelvic floor
The pelvic floor is a group of muscles that support the bladder, bowel, and uterus, and which play a central role in orgasm. During orgasm, these muscles contract rhythmically. If they cannot contract effectively, orgasmic intensity is reduced. If they are chronically overtightened, sensation can be muted and penetration painful, which compounds the difficulty.
A cross-sectional study published in the European Journal of Midwifery (2024) found that 22.9% of menopausal women in their sample reported moderate to severe orgasm difficulty, with a significant association between pelvic floor disorders and sexual dysfunction.
The relationship works in both directions. Weakened pelvic floor muscles (a common consequence of hormonal changes, childbirth, and ageing) reduce the strength of orgasmic contractions. Hypertonic pelvic floor muscles (where the muscles are chronically tight, often as part of a pain-avoidance response) restrict blood flow and sensation in a different way. Generic advice to "do your Kegels" does not account for this distinction, and can be counterproductive for women with hypertonicity.
A 2025 systematic review and meta-analysis confirmed that targeted pelvic floor muscle training improves sexual function in postmenopausal women. This is distinct from general exercise: a specialist pelvic floor physiotherapist will assess whether the issue is weakness, tension, or both, and tailor treatment accordingly.
Other factors that can make it harder
The hormonal changes of menopause do not happen in isolation. Several other factors regularly compound the effect on orgasm, and two of them are almost entirely absent from existing content on this topic.
Sleep deprivation
Night sweats and insomnia are among the most disruptive menopause symptoms, and chronic sleep deprivation has a direct effect on sexual response, mood, and the neurological conditions that support orgasm. A body running on disrupted sleep has less capacity for the physical relaxation and psychological engagement that orgasm requires.
Mood, anxiety, and the attention required for orgasm
Orgasm requires a degree of sustained focus. Anxiety, low mood, and the kind of mental overload that often accompanies menopause, particularly for women in their late 40s and early 50s who are also managing careers, relationships, and caring responsibilities, actively interfere with this. The 2025 BJOG review identifies psychosocial factors as a significant independent contributor to sexual dysfunction at menopause, separate from but interacting with the hormonal causes.
Antidepressants
This is the factor most likely to be affecting women in this audience and least likely to have been discussed with them.
Many women are prescribed SSRIs (selective serotonin reuptake inhibitors) during perimenopause for low mood, anxiety, or symptoms that are subsequently recognised as menopause-related. SSRIs are well-documented to delay or inhibit orgasm in both women and men. For women who were prescribed antidepressants when what they actually needed was hormonal treatment, this creates a double difficulty: the underlying menopause symptoms remain unaddressed while the medication adds a pharmacological barrier to sexual response.
If you are taking antidepressants, particularly if they were prescribed for what may have been menopause symptoms, it is worth raising with a specialist whether your treatment plan could be reviewed. This is not about stopping medication without guidance. It is about ensuring that your full picture has been properly assessed. A narrative review in Expert Review of Endocrinology and Metabolism (2025) identifies this intersection as clinically important and under-addressed in practice.
What can actually help
There is no single treatment for orgasm difficulty during menopause, and the most effective approaches tend to address more than one cause at once. Here is what the evidence supports.
Vaginal oestrogen
Vaginal oestrogen is a topical treatment that helps restore vaginal tissue, making it thicker, more elastic, and more hydrated. Applied locally as a cream, pessary, or ring, it delivers a low dose of oestrogen directly to the tissue without significant absorption into the bloodstream.
By restoring blood flow and tissue integrity to the vagina and vulva, vaginal oestrogen addresses some of the physical mechanisms behind reduced sensitivity and orgasmic difficulty. The BMS GSM Consensus Statement (2025) and the ICSM international consensus (2025) both confirm strong evidence for local oestrogen therapy in treating the genitourinary symptoms that affect sexual function.
For women with concerns about breast cancer risk: vaginal oestrogen is generally considered separately from systemic HRT in terms of risk profile, because of its low systemic absorption. Individual assessment by a specialist is always required.
Systemic HRT
Hormone Replacement Therapy (HRT): a combination of hormones tailored to your symptoms and your body, taken systemically, addresses the broader hormonal deficit. For women whose orgasm difficulty is part of a wider symptom picture including hot flushes, sleep disruption, mood changes, and fatigue, HRT often produces the most comprehensive improvement.
HRT and vaginal oestrogen are frequently used together, since systemic treatment does not always fully address local genital tissue changes.
Testosterone
Testosterone plays a direct role in desire, arousal, and sexual response in women. When levels fall during menopause, the capacity for sexual engagement and the ease of reaching orgasm can both be significantly affected.
A 2024 review in Revista Brasileira de Ginecologia e Obstetrícia confirms that testosterone improves hypoactive sexual desire disorder and plays an important role in desire and orgasm for women post-menopause. Voy members taking testosterone have reported a +65% improvement in libido at 12 months (published in The Journal of Sexual Medicine, 2025).
Testosterone replacement is available at Voy as Testogel, Androfeme, or Voy's own testosterone cream, prescribed by a specialist clinician following assessment. A testosterone blood test taken within the last three months is required before a prescription can be issued. In the UK, testosterone for women is prescribed off-label by specialist doctors meaning it is used outside its original licensed indication, but within an established and evidence-supported clinical framework.
If you have never been offered this conversation, that is not unusual. It is worth asking for.
Pelvic floor physiotherapy
As covered above, a specialist pelvic floor physiotherapist can assess whether weakness, hypertonicity, or a combination is affecting your sexual function, and work with you on a targeted programme. This goes well beyond general advice about pelvic floor exercises and is supported by a 2025 systematic review showing meaningful improvements in sexual function with targeted training.
CBT and psychosexual therapy
Cognitive Behavioural Therapy (CBT): a structured talking therapy that can help manage menopause symptoms alongside or instead of medication, is specifically relevant for orgasm difficulty because of the role that anticipatory anxiety, avoidance, and body image play in the experience. The 2025 narrative review in Expert Review of Endocrinology and Metabolism identifies CBT and mindfulness-based approaches as evidence-based components of a comprehensive plan for female sexual dysfunction at menopause.
CBT does not replace treatment for physical causes. It works alongside them, addressing the psychological feedback loop that can persist even when physical symptoms improve.
Lubricants and vaginal moisturisers
These remain a useful part of the picture. Lubricants reduce friction during sex; vaginal moisturisers used regularly maintain tissue hydration over time. They are most effective when used alongside, not instead of, treatments that address the underlying hormonal causes.
Orgasms do not stop at menopause
This section exists because it is true, and because it is rarely said clearly enough.
With the right treatment and support, many women see significant improvement in their sexual function during and after menopause. The 2025 systematic review of pelvic floor muscle training found meaningful improvements in sexual function. Hormonal treatment produces improvements across desire, arousal, lubrication, and satisfaction. And 93% of Voy members reported improvement in overall quality of life after starting treatment (presented at The Menopause Society 2025; forthcoming in Climacteric): a figure that encompasses sexual wellbeing alongside sleep, mood, energy, and everything else that menopause affects.
Some women also report that the post-menopausal period, particularly once symptoms are well managed, brings its own freedom: less anxiety about contraception, a clearer sense of their own desires, and more confidence in asking for what they want. That is not a silver lining designed to minimise the difficulty. It is simply an honest part of the picture that rarely makes it into the medical literature.
What a Voy menopause consultation covers
For most women, the pathway to good menopause care involves a series of short, unsatisfying appointments where sexual health either does not come up, or is addressed in two minutes at the end. That is a structural problem, not an individual one: a standard GP appointment does not provide the time or the specialist knowledge to work through something as multifactorial as orgasm difficulty during menopause.
At Voy, menopause consultations are 45 minutes, with BMS-trained menopause specialists who understand the full clinical picture. The consultation covers your symptoms across all domains, not just the ones you feel comfortable naming first, and the treatment plan that follows can combine vaginal oestrogen, systemic HRT, testosterone, pelvic floor physiotherapy referral, CBT, nutrition support, and ongoing monitoring.
93% of Voy members reported improvement in overall quality of life after starting treatment (presented at The Menopause Society 2025; forthcoming in Climacteric).
When to seek help, and what to say
If changes to orgasm are affecting your quality of life, your relationship, or how you feel about yourself, that is enough. You do not need to reach a threshold of severity before the conversation is worth having.
A menopause specialist will not be surprised by this. They will not find it awkward. They are used to asking about sexual function in detail, because they know it matters and that most women will not raise it without being asked. Our clinicians are trained to ask the right questions, and support you in feeling comfortable talking about what may considered difficult topics. We are here to help, not pass judgement.
If you are not sure how to start the conversation, something direct usually works best: "I've noticed orgasms have changed since I started perimenopause" or "I'm finding it much harder to reach orgasm than I used to and I'd like to understand why." That is enough to open the discussion.
